Stay updated on Apremilast-Dupilumab Combo in Eczema Clinical Trial
Sign up to get notified when there's something new on the Apremilast-Dupilumab Combo in Eczema Clinical Trial page.

Latest updates to the Apremilast-Dupilumab Combo in Eczema Clinical Trial page
- Check6 days agoChange DetectedThe page footer now shows Revision: v3.5.5, replacing v3.5.4, indicating a site version update. This change appears to be behind-the-scenes and does not alter study content or user-facing functionality.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check28 days agoChange DetectedRevision: v3.5.4 was added in the page footer, replacing the previous Revision: v3.5.3. This represents a small version update and does not modify study details or primary content on the page.SummaryDifference0.1%

- Check49 days agoChange DetectedUpdates the ClinicalTrials.gov page revision indicator from v3.5.2 to v3.5.3 without changing the study content shown in the record.SummaryDifference0.1%

- Check56 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check85 days agoChange DetectedPage revision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check92 days agoChange DetectedFooter revision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

Stay in the know with updates to Apremilast-Dupilumab Combo in Eczema Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Apremilast-Dupilumab Combo in Eczema Clinical Trial page.